Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by VancouverPigon Nov 20, 2017 3:21pm

74 Views

Post# 26998513

RE:RE:RE:RE:Warrant extension - whats up?

So, warrants not extended and expire or Warrants in the money and exercised? I think at this point warrants in the money and exercised is a better sign for investors.

Signed: VancouverPig votes....FOR exercise.... WITH HELD expire...because there is probably no AGAINST vote either exercise or expire. That's how shareholders rights are suppressed.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages